Autotaxin inhibitor successful in the first trial in diffuse cutaneous systemic sclerosis Presented ByProf. Dinesh Khanna, University of Michigan Scleroderma Program, USA TrialPhase 2, NOVESA ConferenceACR 2020 TypePeer-reviewed article 18 January 2021 11:02